N-Acetylcysteine /tab

Phase 3Small molecule

FFar Eastern Memorial Hospital

N-Acetylcysteine /tab is one of 48 small molecule programs targeting Mucositis. It is currently in Phase 3.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

MucositisActive, not recruiting

MucositisPhase 3

Active, not recruiting

Competition

Competitive Landscape

63 competitors in Mucositis

#DrugCompanyPhaseTrials

Neo-Synephrine

EExela Pharma Sciences, LLC.

Tylenol

Kenalog

BBausch Health Americas, Inc.

Approved

—4

Ethyol

LLegacy Health System

Advil

1 6

Nubain

AAultman Health Foundation

Phase 3

1 7

Duragesic

CCephalon

Phase 3

1 8

Neurontin

VViatris Specialty LLC

Phase 3

1 9

MS Contin

HHikma Pharmaceuticals LLC

Phase 3

1 10

Diflucan

PPfizer's Upjohn has merged with Mylan to form Viatris Inc.

Phase 3

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Cardiopulmonary Bypass1 trial

Acetylcysteine Against Acute Renal Insult During Cardiopulmonary Bypass.

Suspended·FFar Eastern Memorial Hospital·Phase 4·NCT00190034·60 enrolled

Mucositis1 trial

Safety and Efficacy of N-Acetylcysteine Mouthwash in Prevention of Mucositis in HSCT Patients

Active, not recruiting·TTehran University of Medical Sciences·Phase 3·NCT07325383·106 enrolled

Sources

References

[1]
ClinicalTrials.gov — 2 trial records for N-Acetylcysteine /tab. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — N-Acetylcysteine /tab compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for N-Acetylcysteine /tab. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Far Eastern Memorial Hospital company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 3[1]
Company: FFar Eastern Memorial Hospital

N-Acetylcysteine /tab

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Cardiopulmonary Bypass1 trial

Mucositis1 trial

References

Drug Info

Quick Facts

Related News